Blood money: Bayer's inventory of HIV-contaminated blood products and third world hemophiliacs - PubMed

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. This article presents an overlooked case of research misconduct and violations of basic principles of medical and business ethics. When Bayer's Cutter Laboratories realized that their blood products, Factor VIII and IX or antihemophiliac factor (AHF), were contaminated with human immunodeficiency virus (HIV), the financial investment in the product was considered too high to destroy the inventory. Cutter misrepresented the results of its own research and sold the contaminated AHF to overseas markets in Asia and Latin America without the precaution

Blood money: Bayer's inventory of HIV-contaminated blood products and third world hemophiliacs - PubMed Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Access keys NCBI Homepage MyNCBI Homepage M

related reading

• Acquired Hemophilia A - Symptoms, Causes, Treatment | NORDrarediseases.org
• Receptor mediated uptake of peptides that bind the human transferrin receptor - PubMedpubmed.ncbi.nlm.nih.gov
• The effect of ABO blood group on the diagnosis of von Willebrand disease - PubMedpubmed.ncbi.nlm.nih.gov
• Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children - PubMedpubmed.ncbi.nlm.nih.gov
• Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov
• Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness - PubMedpubmed.ncbi.nlm.nih.gov
• StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• On the 'discovery' of vitamin A - PubMedpubmed.ncbi.nlm.nih.gov
• The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia - PubMedpubmed.ncbi.nlm.nih.gov
• ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? - PubMedpubmed.ncbi.nlm.nih.gov
• Guidance for Industryfda.gov
• The spread of true and false news online - PubMedpubmed.ncbi.nlm.nih.gov